Molly Stevens

Professor Dame Molly Stevens holds the John Black Professorship of Bionanoscience at the University of Oxford's Department of Physiology, Anatomy & Genetics and Institute of Biomedical Engineering, while serving as Deputy Director of the Kavli Institute for Nanoscience Discovery. She maintains part-time roles at Imperial College London and the Karolinska Institutet, Sweden. Her research focuses on biosensing, regenerative medicine, and biomaterials, with over 400 publications and an H-index exceeding 100. Stevens is a serial entrepreneur, co-founding four biotech companies and holding numerous patents.

Education: PhD in Materials Science (University of Nottingham), postdoctoral training at MIT. Research interests include advanced diagnostics, bio-material interfaces, bioelectronics, and digital medicine leveraging AI. She leads the UK Regenerative Medicine Hub and the EPSRC i-sense collaboration.

Awards include the Novo Nordisk Award (2023), MRS Mid-Career Researcher Award (2022), and American Chemical Society Colloid Chemistry Award (2020). A Fellow of the Royal Society, Royal Academy of Engineering, and multiple international academies, she champions interdisciplinary innovation and healthcare democratization.

Advising and funding: Supervises a multidisciplinary team of over 40 researchers, with grants from ERC, UKRI, Wellcome Trust, and industry partners. Her Stevens Group develops biomaterials for soft robotics, tissue engineering, and wearable diagnostics.